166 related articles for article (PubMed ID: 23452234)
1. Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.
Mares J; Szakacsova M; Soukup V; Duskova J; Horinek A; Babjuk M
Neoplasma; 2013; 60(3):295-301. PubMed ID: 23452234
[TBL] [Abstract][Full Text] [Related]
2. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
[TBL] [Abstract][Full Text] [Related]
3. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
4. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
5. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.
Birkhahn M; Mitra AP; Williams AJ; Lam G; Ye W; Datar RH; Balic M; Groshen S; Steven KE; Cote RJ
Eur Urol; 2010 Jan; 57(1):12-20. PubMed ID: 19762144
[TBL] [Abstract][Full Text] [Related]
6. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
8. Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.
Descotes F; Dessen P; Bringuier PP; Decaussin M; Martin PM; Adams M; Villers A; Lechevallier E; Rebillard X; Rodriguez-Lafrasse C; Devonec M; Paparel P; Perrin P; Lazar V; Ruffion A
BJU Int; 2014 Feb; 113(2):333-42. PubMed ID: 24053469
[TBL] [Abstract][Full Text] [Related]
9. Screening of differentially expressed genes related to bladder cancer and functional analysis with DNA microarray.
Huang YD; Shan W; Zeng L; Wu Y
Asian Pac J Cancer Prev; 2013; 14(8):4553-7. PubMed ID: 24083701
[TBL] [Abstract][Full Text] [Related]
10. Pattern of somatostatin receptors expression in normal and bladder cancer tissue samples.
Karavitakis M; Msaouel P; Michalopoulos V; Koutsilieris M
Anticancer Res; 2014 Jun; 34(6):2937-42. PubMed ID: 24922657
[TBL] [Abstract][Full Text] [Related]
11. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
Kang HW; Seo SP; Byun YJ; Piao XM; Kim YH; Jeong P; Ha YS; Kim WT; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2018 Aug; 16(4):274-280. PubMed ID: 29571585
[TBL] [Abstract][Full Text] [Related]
12. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study.
Schultz IJ; Wester K; Straatman H; Kiemeney LA; Babjuk M; Mares J; Willems JL; Swinkels DW; Witjes JA; de Kok JB; Malmström PU
Int J Cancer; 2006 Oct; 119(8):1915-9. PubMed ID: 16721812
[TBL] [Abstract][Full Text] [Related]
14. Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer.
Blanca A; Sanchez-Gonzalez A; Requena MJ; Carrasco-Valiente J; Gomez-Gomez E; Cheng L; Cimadamore A; Montironi R; Lopez-Beltran A
APMIS; 2019 Aug; 127(8):545-553. PubMed ID: 31231851
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.
Wang N; Zhou F; Xiong H; Du S; Ma J; Okai I; Wang J; Suo J; Hao L; Song Y; Hu J; Shao S
Anat Rec (Hoboken); 2012 May; 295(5):748-57. PubMed ID: 22419659
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures for the prediction of response to Bacillus Calmette-Guerin immunotherapy in primary pT1 bladder cancers.
Kim YJ; Ha YS; Kim SK; Yoon HY; Lym MS; Kim MJ; Moon SK; Choi YH; Kim WJ
Clin Cancer Res; 2010 Apr; 16(7):2131-7. PubMed ID: 20233890
[TBL] [Abstract][Full Text] [Related]
17. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.
Kim WJ; Kim EJ; Kim SK; Kim YJ; Ha YS; Jeong P; Kim MJ; Yun SJ; Lee KM; Moon SK; Lee SC; Cha EJ; Bae SC
Mol Cancer; 2010 Jan; 9():3. PubMed ID: 20059769
[TBL] [Abstract][Full Text] [Related]
20. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
